
    
      -  Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by
           their rheumatologist prescription methotrexate will be included.

        -  Patients will participate in a prospective and observational study in which the response
           to methotrexate will be assessed by ultrasound (US) of joints and tendons.

        -  The main objective of the study is the change in B mode and Doppler mode US after 24
           weeks of methotrexate treatment.
    
  